Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

The Importance of Imaging in Radiation Oncology for National Clinical Trials Network Protocols

Journal Article · · International Journal of Radiation Oncology, Biology and Physics
;  [1]; ;  [2];
  1. Imaging and Radiation Oncology Core QA Center Rhode Island, University of Massachusetts Medical School, Lincoln, Rhode Island (United States)
  2. Imaging and Radiation Oncology Core RT QA Center Philadelphia, American College of Radiology Center for Research, Philadelphia (United States)

Imaging is essential in successfully executing radiation therapy (RT) in oncology clinical trials. As technically sophisticated diagnostic imaging and RT were incorporated into trials, quality assurance in the National Clinical Trials Network groups entered a new era promoting image acquisition and review. Most trials involving RT require pre- and post-therapy imaging for target validation and outcome assessment. The increasing real-time (before and during therapy) imaging and RT object reviews are to ensure compliance with trial objectives. Objects easily transmit digitally for review from anywhere in the world. Physician interpretation of imaging and image application to RT treatment plans is essential for optimal trial execution. Imaging and RT data sets are used to credential RT sites to confirm investigator and institutional ability to meet trial target volume delineation and delivery requirements. Real-time imaging and RT object reviews can be performed multiple times during a trial to assess response to therapy and application of RT objects. This process has matured into an effective data management mechanism. When necessary, site and study investigators review objects together through web media technologies to ensure the patient is enrolled on the appropriate trial and the intended RT is planned and executed in a trial-compliant manner. Real-time imaging review makes sure: (1) the patient is entered and eligible for the trial, (2) the patient meets trial-specific adaptive therapy requirements, if applicable, and (3) the intended RT is according to trial guidelines. This review ensures the study population is uniform and the results are believable and can be applied to clinical practice.

OSTI ID:
23100743
Journal Information:
International Journal of Radiation Oncology, Biology and Physics, Journal Name: International Journal of Radiation Oncology, Biology and Physics Journal Issue: 4 Vol. 102; ISSN IOBPD3; ISSN 0360-3016
Country of Publication:
United States
Language:
English

Similar Records

Processes for Quality Improvements in Radiation Oncology Clinical Trials
Journal Article · Thu May 01 00:00:00 EDT 2008 · International Journal of Radiation Oncology, Biology and Physics · OSTI ID:21124229

SU-F-J-49: IGRT Credentialing in NCTN Trials
Journal Article · Wed Jun 15 00:00:00 EDT 2016 · Medical Physics · OSTI ID:22632181

SU-F-T-237: The Imaging and Radiation Oncology Core (IROC) Cooperatives Activities Supporting the NCI’s National Clinical Trial Network
Journal Article · Wed Jun 15 00:00:00 EDT 2016 · Medical Physics · OSTI ID:22648853